[HTML][HTML] Role of inflammatory cytokines in COVID-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs …

AA Rabaan, SH Al-Ahmed, J Muhammad, A Khan… - Vaccines, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a severe pandemic of the current century. The vicious …

[HTML][HTML] The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: lessons learned from major clinical studies

C Chakraborty, AR Sharma, M Bhattacharya… - Frontiers in …, 2021 - frontiersin.org
SARS-CoV-2 has spread across the globe in no time. In the beginning, people suffered due
to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still …

[HTML][HTML] Covid-19 and development of heart failure: mystery and truth

H Onohuean, HM Al-Kuraishy, AI Al-Gareeb… - Naunyn-Schmiedeberg's …, 2021 - Springer
Abstract Coronavirus disease 2019 (Covid-19) is a novel worldwide pandemic caused by a
novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). During Covid-19 …

[HTML][HTML] COVID-19 and atrial fibrillation: Intercepting lines

M Donniacuo, A De Angelis, C Rafaniello… - Frontiers in …, 2023 - frontiersin.org
Almost 20% of COVID-19 patients have a history of atrial fibrillation (AF), but also a new-
onset AF represents a frequent complication in COVID-19. Clinical evidence demonstrates …

Potential pathophysiological mechanisms underlying multiple organ dysfunction in cytokine release syndrome

P Chen, Y Tang, W He, R Yang, Z Lan… - Mediators of …, 2022 - Wiley Online Library
In recent decades, many serious respiratory infections have broken out all over the world,
including SARS‐CoV, MERS, and COVID‐19. They are characterized by strong infectivity …

Interaction of COVID-19 With Common Cardiovascular Disorders

PK Boulos, SV Freeman, TD Henry, E Mahmud… - Circulation …, 2023 - Am Heart Assoc
The onset and widespread dissemination of the severe acute respiratory syndrome
coronavirus-2 in late 2019 impacted the world in a way not seen since the 1918 H1N1 …

[HTML][HTML] The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?

L Czupryniak, D Dicker, R Lehmann, M Prázný… - Cardiovascular …, 2021 - Springer
Patients with Covid-19 place new challenges on the management of type 2 diabetes,
including the questions of whether glucose-lowering therapy should be adjusted during …

[HTML][HTML] A real Pandora's box in pandemic times: a narrative review on the acute cardiac injury due to COVID-19

AS Timpau, RS Miftode, D Leca, R Timpau, IL Miftode… - Life, 2022 - mdpi.com
The intricate relationship between severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) and the cardiovascular system is an extensively studied pandemic topic, as there is …

Unravelling the potentialities of tocilizumab for the development of a potential immunotherapeutic regimen against COVID-19—A narrative review

M Dhawan, K Dhama, M Parmar, A Sharma… - Journal of Applied …, 2021 - japsonline.com
The severity of COVID-19 (coronavirus disease 2019) disease caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2) has been associated with …

[HTML][HTML] Case report: successful treatment of a child with COVID-19 reinfection-induced fulminant myocarditis by cytokine-adsorbing oXiris® hemofilter continuous …

PH Phan, DT Nguyen, NH Dao, HTT Nguyen… - Frontiers in …, 2022 - frontiersin.org
Background: Indirect cardiomyocyte damage-related hyperinflammatory response is one of
the key mechanisms in Covid-19-induced fulminant myocarditis. In addition to the clinical …